Lemborexant for insomnia in adults with psychiatric disorders: A 1-week, open-label study.
作者信息
Kishi Taro, Sakuma Kenji, Okuya Makoto, Iwata Nakao
机构信息
Department of Psychiatry Fujita Health University School of Medicine Toyoake Aichi Japan.
出版信息
PCN Rep. 2022 Jun 30;1(3):e23. doi: 10.1002/pcn5.23. eCollection 2022 Sep.
Abstract
摘要
相似文献
1
Lemborexant for insomnia in adults with psychiatric disorders: A 1-week, open-label study.lemborexant用于患有精神疾病的成人失眠症：一项为期1周的开放标签研究。
PCN Rep. 2022 Jun 30;1(3):e23. doi: 10.1002/pcn5.23. eCollection 2022 Sep.
2
Efficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder.lemborexant对≥65岁失眠障碍成人的疗效。
Neurol Ther. 2024 Aug;13(4):1081-1098. doi: 10.1007/s40120-024-00622-9. Epub 2024 May 15.
3
Improvement in fatigue and sleep measures with the dual orexin receptor antagonist lemborexant in adults with insomnia disorder.在失眠障碍的成年人中，双重食欲素受体拮抗剂lemborexant 可改善疲劳和睡眠指标。
Postgrad Med. 2022 Apr;134(3):316-325. doi: 10.1080/00325481.2022.2049553. Epub 2022 Mar 20.
4
Lemborexant, an orexin receptor antagonist sedative-hypnotic: Is it useful for insomnia in psychiatric disorders?雷美替胺，一种食欲素受体拮抗剂镇静催眠药：它对精神障碍相关失眠症有效吗？
Australas Psychiatry. 2022 Aug;30(4):530-532. doi: 10.1177/10398562221092310. Epub 2022 May 1.
5
Lemborexant for the Treatment of Insomnia in Patients From China: Four Case Studies.伦博瑞生用于治疗中国患者失眠症：四例病例研究
Cureus. 2024 Jul 16;16(7):e64655. doi: 10.7759/cureus.64655. eCollection 2024 Jul.
6
Perception of Lemborexant Effectiveness as Assessed by the Patient Global Impression-Insomnia Questionnaire.通过患者总体印象-失眠问卷评估的lemborexant有效性感知。
Nat Sci Sleep. 2025 Apr 8;17:557-570. doi: 10.2147/NSS.S499090. eCollection 2025.
7
Efficacy and safety of insomnia treatment with lemborexant in older adults: analyses from three clinical trials.在老年人中使用雷美替胺治疗失眠的疗效和安全性：三项临床试验分析。
Drugs Aging. 2024 Sep;41(9):741-752. doi: 10.1007/s40266-024-01135-8. Epub 2024 Aug 9.
8
Efficacy and safety of Lemborexant in treating adult patients with insomnia in China: a single-center, retrospective observational study.在中国，莱莫西坦治疗成年失眠患者的疗效和安全性：一项单中心回顾性观察研究。
Front Neurol. 2025 Mar 14;16:1495965. doi: 10.3389/fneur.2025.1495965. eCollection 2025.
9
Comparative efficacy of lemborexant and other insomnia treatments: a network meta-analysis.来普替唑仑与其他失眠治疗药物的疗效比较：一项网络荟萃分析。
J Manag Care Spec Pharm. 2021 Sep;27(9):1296-1308. doi: 10.18553/jmcp.2021.21011. Epub 2021 Jun 12.
10
The effect of lemborexant for insomnia disorder.伦扎必利对失眠症的疗效。
SAGE Open Med. 2021 Aug 18;9:20503121211039098. doi: 10.1177/20503121211039098. eCollection 2021.
引用本文的文献
1
Short-Term Efficacy and Safety of Suvorexant and Lemborexant: A Retrospective Study.苏沃雷生和伦博雷生的短期疗效与安全性：一项回顾性研究。
Cureus. 2024 Oct 8;16(10):e71049. doi: 10.7759/cureus.71049. eCollection 2024 Oct.
2
Orexin receptor antagonists in the treatment of insomnia associated with psychiatric disorders: a systematic review.食欲素受体拮抗剂治疗与精神障碍相关的失眠：系统评价。
Transl Psychiatry. 2024 Sep 14;14(1):374. doi: 10.1038/s41398-024-03087-4.
3
Efficacy and Safety of Transitioning to Lemborexant from Z-drug, Suvorexant, and Ramelteon in Japanese Insomnia Patients: An Open-label, Multicenter Study.在日本失眠患者中从 Z 药（右佐匹克隆、唑吡坦）和雷美尔通转换为仑替佐明的疗效和安全性：一项开放标签、多中心研究。
Adv Ther. 2024 Apr;41(4):1728-1745. doi: 10.1007/s12325-024-02811-2. Epub 2024 Mar 9.
本文引用的文献
1
Evidence-based insomnia treatment strategy using novel orexin antagonists: A review.基于证据的新型食欲素拮抗剂治疗失眠策略：综述。
Neuropsychopharmacol Rep. 2021 Dec;41(4):450-458. doi: 10.1002/npr2.12205. Epub 2021 Sep 23.
2
Lemborexant vs suvorexant for insomnia: A systematic review and network meta-analysis.莱莫雷生与苏沃雷生治疗失眠的比较：一项系统评价与网状Meta分析
J Psychiatr Res. 2020 Sep;128:68-74. doi: 10.1016/j.jpsychires.2020.05.025. Epub 2020 May 28.
3
Sleep complaints are associated with increased suicide risk independently of psychiatric disorders: results from a national 3-year prospective study.睡眠问题与自杀风险增加有关，与精神障碍无关：一项全国性的 3 年前瞻性研究结果。
Mol Psychiatry. 2021 Jun;26(6):2126-2136. doi: 10.1038/s41380-020-0735-3. Epub 2020 Apr 30.
4
Suvorexant for insomnia in patients with psychiatric disorder: A 1-week, open-label study.苏沃雷生用于精神疾病患者失眠的治疗：一项为期1周的开放标签研究。
Neuropsychopharmacol Rep. 2019 Sep;39(3):252-255. doi: 10.1002/npr2.12069. Epub 2019 Jul 8.
5
Insomnia as a predictor of mental disorders: A systematic review and meta-analysis.失眠作为精神障碍的预测因子：系统评价和荟萃分析。
Sleep Med Rev. 2019 Feb;43:96-105. doi: 10.1016/j.smrv.2018.10.006. Epub 2018 Nov 16.
6
Insomnia as a Precipitating Factor in New Onset Mental Illness: a Systematic Review of Recent Findings.失眠作为新发精神疾病的促发因素：近期研究结果的系统综述
Curr Psychiatry Rep. 2017 Aug;19(8):44. doi: 10.1007/s11920-017-0802-x.
Zotero 插件